Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity

  • Paola Lucia Minciullo
  • Antonino Catalano
  • Giuseppe Mandraffino
  • Marco Casciaro
  • Andrea Crucitti
  • Giuseppe Maltese
  • Nunziata Morabito
  • Antonino Lasco
  • Sebastiano Gangemi
  • Giorgio Basile
Review

Abstract

Longevity and aging are two sides of the same coin, as they both derive from the interaction between genetic and environmental factors. Aging is a complex, dynamic biological process characterized by continuous remodeling. One of the most recent theories on aging focuses on immune response, and takes into consideration the activation of subclinical, chronic low-grade inflammation which occurs with aging, named “inflammaging”. Long-lived people, especially centenarians, seem to cope with chronic subclinical inflammation through an anti-inflammatory response, called therefore “anti-inflammaging”. In the present review, we have focused our attention on the contrast between inflammaging and anti-inflammaging systems, by evaluating the role of cytokines and their impact on extreme longevity. Cytokines are the expression of a network involving genes, polymorphisms and environment, and are involved both in inflammation and anti-inflammation. We have described the role of IL-1, IL-2, IL-6, IL-12, IL-15, IL-18, IL-22, IL-23, TNF-α, IFN-γ as pro-inflammatory cytokines, of IL-1Ra, IL-4, IL-10, TGF-β1 as anti-inflammatory cytokines, and of lipoxin A4 and heat shock proteins as mediators of cytokines. We believe that if inflammaging is a key to understand aging, anti-inflammaging may be one of the secrets of longevity.

Keywords

Inflammaging Anti-inflammaging Cytokine Aging Longevity 

Abbreviations

IL

Interleukin

NK

Natural killer cells

TNF

Tumor necrosis factor

IFN

Interferon

IL-18BP

IL-18 binding protein

SNPs

Single nucleotide polymorphisms

IL-1Ra

IL-1 receptor antagonist

Hsp

Heat shock proteins

LX

Lipoxin

TGF

Transforming growth factor

References

  1. Akdis M, Burgler S, Crameri R et al (2011) Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127:701–721PubMedCrossRefGoogle Scholar
  2. Alberti S, Cevenini E, Ostan R et al (2006) Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans. Mech Ageing Dev 127:560–566PubMedCrossRefGoogle Scholar
  3. Antonicelli R, Olivieri F, Bonafè M et al (2005) The interleukin-6 −174 G>C promoter polymorphism is associated with an higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 103:266–271PubMedCrossRefGoogle Scholar
  4. Ariel A, Chiang N, Arita M et al (2003) Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 170:6266–6272PubMedCrossRefGoogle Scholar
  5. Baker SJ, Reddy EP (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1–9PubMedGoogle Scholar
  6. Basile G, Gangemi S, Lo Balbo C et al (2003) Correlation between serum retinol and alpha-tocopherol levels in centenarians. J Nutr Sci Vitaminol 49:287–288PubMedCrossRefGoogle Scholar
  7. Basile G, Paffumi I, D’Angelo AG et al (2012) Healthy centenarians show high levels of circulating interleukin-22 (IL-22). Arch Gerontol Geriatr 54:459–461PubMedCrossRefGoogle Scholar
  8. Biagi E, Nylund L, Candela M et al (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5:e10667PubMedPubMedCentralCrossRefGoogle Scholar
  9. Billiau A, Heremans H, Vermeire K et al (1998) Immunomodulatory properties of interferon-γ. An update. Ann N Y Acad Sci 856:22–32PubMedCrossRefGoogle Scholar
  10. Bonnans C, Fukunaga K, Levy MA et al (2006) Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am J Pathol 168:1064–1072PubMedPubMedCentralCrossRefGoogle Scholar
  11. Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149–160PubMedCrossRefGoogle Scholar
  12. Bruunsgaard H, Pedersen AN, Schroll M et al (1999a) Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol 118:235–241PubMedPubMedCentralCrossRefGoogle Scholar
  13. Bruunsgaard H, Skinhøj P, Qvist J et al (1999b) Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis 180:551–554PubMedCrossRefGoogle Scholar
  14. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JB et al (2003) Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 115:278–283PubMedCrossRefGoogle Scholar
  15. Bruunsgaard H, Benfield TL, Andersen-Ranberg K et al (2004) The tumor necrosis factor alpha −308G>A polymorphism is associated with dementia in the oldest old. J Am Geriatr Soc 52:1361–1366PubMedCrossRefGoogle Scholar
  16. Candore G, Lorenzo G, Caruso C et al (1992) The effect of age on mitogen responsive T cell precursors in human beings is completely restored by interleukin-2. Mech Ageing Dev 63:297–307PubMedCrossRefGoogle Scholar
  17. Carlsson AC, Juhlin CC, Larsson TE et al (2014a) Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes–findings from two community based cohorts of elderly. Atherosclerosis 237:236–242PubMedCrossRefGoogle Scholar
  18. Carlsson AC, Larsson TE, Helmersson-Karlqvist J et al (2014b) Soluble TNF receptors and kidney dysfunction in the elderly. J Am Soc Nephrol 25:1313–1320PubMedPubMedCentralCrossRefGoogle Scholar
  19. Carrieri G, Marzi E, Olivieri F et al (2004) The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell 3:443–448PubMedCrossRefGoogle Scholar
  20. Caruso C, Candore G, Cigna D et al (1996) Cytokine production pathway in the elderly. Immunol Res 15:84–90PubMedCrossRefGoogle Scholar
  21. Caruso C, Candore G, Colonna-Romano G et al (2005) Inflammation and life-span. Science 307:208–209PubMedCrossRefGoogle Scholar
  22. Caruso C, Balistreri CR, Crivello A et al (2007) The genetics of innate immunity and inflammation in ageing, age-related diseases and longevity. In: Pawelec G (ed) Immunosenescence. Landes Bioscience and Springer Science + Business Media, AustinGoogle Scholar
  23. Cavallone L, Bonafè M, Olivieri F et al (2003) The role of IL-1 gene cluster in longevity: a study in Italian population. Mech Ageing Dev 124:533–538PubMedCrossRefGoogle Scholar
  24. Cederholm T, Persson M, Andersson P et al (2007) Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients. J Intern Med 262:215–223PubMedCrossRefGoogle Scholar
  25. Compté N, Zouaoui Boudjeltia K, Vanhaeverbeek M et al (2013) Frailty in old age is associated with decreased interleukin-12/23 production in response to Toll-like receptor ligation. PLoS One 8:e65325PubMedPubMedCentralCrossRefGoogle Scholar
  26. Coppolino G, Basile G, Bolignano D et al (2007) Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. J Am Geriatr Soc 55:1693–1694PubMedCrossRefGoogle Scholar
  27. de Araújo AL, Silva LC, Fernandes JR et al (2013) Preventing or reversing immunosenescence: can exercise be an immunotherapy? Immunotherapy 5:879–893PubMedCrossRefGoogle Scholar
  28. de Toda IM, De la Fuente M (2015) The role of Hsp70 in oxi-inflamm-aging and its use as a potential biomarker of lifespan. Biogerontology 16:709–721CrossRefGoogle Scholar
  29. Di Bona D, Vasto S, Capurso C et al (2009) Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev 8:36–42PubMedCrossRefGoogle Scholar
  30. Di Iorio A, Ferrucci L, Sparvieri E et al (2003) Serum IL-1beta levels in health and disease: a population-based study. The InCHIANTI study. Cytokine 22:198–205PubMedCrossRefGoogle Scholar
  31. Di Stefano R, Felice F, Feriani R et al (2013) Endothelial progenitor cells, cardiovascular risk factors and lifestyle modifications. Intern Emerg Med 8(Suppl 1):S47–S49PubMedCrossRefGoogle Scholar
  32. Diniz BS, Teixeira AL, Ojopi EB et al (2010) Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer’s disease. J Alzheimers Dis 22:1305–1311PubMedGoogle Scholar
  33. Duvallet E, Semerano L, Assier E et al (2011) Interleukin-23: a key cytokine in inflammatory diseases. Ann Med 43:503–511PubMedCrossRefGoogle Scholar
  34. Eisenberg SP, Evans RJ, Arend WP et al (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341–346PubMedCrossRefGoogle Scholar
  35. Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41:176–181PubMedCrossRefGoogle Scholar
  36. Faassen AE, O’Leary JJ, Rodysill KJ et al (1989) Diminished heat-shock protein synthesis following mitogen stimulation of lymphocytes from aged donors. Exp Cell Res 183:326–334PubMedCrossRefGoogle Scholar
  37. Fehniger TA, Caligiuri MA (2001) Interleukin 15: biology and relevance to human disease. Blood 97:14–32PubMedCrossRefGoogle Scholar
  38. Ferrucci L, Corsi A, Lauretani F et al (2005) The origins of age-related proinflammatory state. Blood 105:2294–2299PubMedCrossRefGoogle Scholar
  39. Forsey RJ, Thompson JM, Ernerudh J et al (2003) Plasma cytokine profiles in elderly humans. Mech Ageing Dev 124:487–493PubMedCrossRefGoogle Scholar
  40. Franceschi C, Bonafè M, Valensin S et al (2000a) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254PubMedCrossRefGoogle Scholar
  41. Franceschi C, Motta L, Valensin S et al (2000b) Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging 12:77–84PubMedGoogle Scholar
  42. Franceschi C, Olivieri F, Marchegiani F et al (2005) Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev 126:351–361PubMedCrossRefGoogle Scholar
  43. Franceschi C, Capri M, Monti D et al (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105PubMedCrossRefGoogle Scholar
  44. Gangemi S, Basile G, Merendino RA et al (2003) Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity? Exp Gerontol 38:669–672PubMedCrossRefGoogle Scholar
  45. Gangemi S, Basile G, Monti D et al (2005a) Age-related modifications in circulating IL-15 levels in humans. Mediators Inflamm 2005:245–247PubMedPubMedCentralCrossRefGoogle Scholar
  46. Gangemi S, Pescara L, D’Urbano E et al (2005b) Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol 40:612–614PubMedCrossRefGoogle Scholar
  47. Giacconi R, Cipriano C, Albanese F et al (2004) −174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol 39:621–628PubMedCrossRefGoogle Scholar
  48. Gillis S, Kozak R, Durante M et al (1981) Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 67:937–942PubMedPubMedCentralCrossRefGoogle Scholar
  49. Giovannini S, Onder G, Liperoti R et al (2011) Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc 59:1679–1685PubMedPubMedCentralCrossRefGoogle Scholar
  50. Gorelik L, Flavell RA (2002) Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2:46–53PubMedCrossRefGoogle Scholar
  51. Halper B, Hofmann M, Oesen S et al (2015) Influence of age and physical fitness on miRNA-21, TGF-β and its receptors in leukocytes of healthy women. Exerc Immunol Rev 21:154–163PubMedGoogle Scholar
  52. Hoffmann SC, Stanley EM, Darrin Cox E et al (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 72:1444–1450PubMedCrossRefGoogle Scholar
  53. József L, Zouki C, Petasis NA et al (2002) Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 99:13266–13271PubMedPubMedCentralCrossRefGoogle Scholar
  54. Jylhä M, Paavilainen P, Lehtimäki T et al (2007) Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci 62:1016–1021PubMedCrossRefGoogle Scholar
  55. Kamimura D, Ishihara K, Hirano T (2003) IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149:1–38PubMedGoogle Scholar
  56. Kanaoka Y, Boyce JA (2004) Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 173:1503–1510PubMedCrossRefGoogle Scholar
  57. Kayaaltı Z, Sahiner L, Durakoğlugil ME et al (2011) Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population. Arch Gerontol Geriatr 53:354–358PubMedCrossRefGoogle Scholar
  58. Khabour OF, Barnawi JM (2010) Association of longevity with IL-10 -1082 G/A and TNF-alpha-308 G/A polymorphisms. Int J Immunogenet 37:293–298PubMedCrossRefGoogle Scholar
  59. Kotenko SV (2002) The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev 13:223–240PubMedCrossRefGoogle Scholar
  60. Krabbe KS, Bruunsgaard H, Hansen CM et al (2001) Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 8:333–338PubMedPubMedCentralGoogle Scholar
  61. Larbi A, Franceschi C, Mazzatti D et al (2008) Aging of the immune system as a prognostic factor for human longevity. Physiology 23:64–74PubMedCrossRefGoogle Scholar
  62. Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGFbeta. Annu Rev Immunol 16:137–161PubMedCrossRefGoogle Scholar
  63. Lin Y, Nakachi K, Ito Y et al (2009) Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults. Dis Markers 27:23–28PubMedPubMedCentralCrossRefGoogle Scholar
  64. Lio D, Scola L, Crivello A et al (2002a) Allele frequencies of +874T−>A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 37:315–319PubMedCrossRefGoogle Scholar
  65. Lio D, Scola L, Crivello A et al (2002b) Gender-specific association between −1082 IL-10 promoter polymorphism and longevity. Genes Immun 3:30–33PubMedCrossRefGoogle Scholar
  66. Lio D, Candore G, Crivello A et al (2004) Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 41:790–794PubMedPubMedCentralCrossRefGoogle Scholar
  67. Mallat Z, Corbaz A, Scoazec A et al (2001) Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104:1598–1603PubMedCrossRefGoogle Scholar
  68. Mandraffino G, Sardo MA, Riggio S et al (2012) Circulating progenitor cells and the elderly: a seven-year observational study. Exp Gerontol 47:394–400PubMedCrossRefGoogle Scholar
  69. Matteini AM, Li J, Lange EM et al (2014) Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults. Cytokine 65:10–16PubMedPubMedCentralCrossRefGoogle Scholar
  70. McElhaney JE, Zhou X, Talbot HK et al (2012) The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30:2060–2067PubMedPubMedCentralCrossRefGoogle Scholar
  71. McMahon B, Godson C (2004) Lipoxins: endogenous regulators of inflammation. Am J Physiol Renal Physiol 286:F189–F201PubMedCrossRefGoogle Scholar
  72. Michaud M, Balardy L, Moulis G et al (2013) Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 14:877–882PubMedCrossRefGoogle Scholar
  73. Mooradian AD, Reed RL, Osterweil D et al (1991) Detectable serum levels of tumor necrosis factor alpha may predict early mortality in elderly institutionalized patients. J Am Geriatr Soc 39:891–894PubMedCrossRefGoogle Scholar
  74. Motta M, Malaguarnera M, Ferrari E et al (2007) Genealogy of Centenarians and their relatives: a study of 12 families. Arch Gerontol Geriatr 45:97–102PubMedPubMedCentralCrossRefGoogle Scholar
  75. Myśliwska J, Bryl E, Foerster J et al (1998) Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status. Mech Ageing Dev 100:313–328PubMedCrossRefGoogle Scholar
  76. Nakanishi K, Yoshimoto T, Tsutsui H et al (2001) Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12:53–72PubMedCrossRefGoogle Scholar
  77. Naumova E, Mihaylova A, Ivanova M et al (2004) Immunological markers contributing to successful aging in Bulgarians. Exp Gerontol 39:637–644PubMedCrossRefGoogle Scholar
  78. Nicita-Mauro V, Lo Balbo C, Mento A et al (2008) Smoking, aging and the centenarians. Exp Gerontol 43:95–101PubMedCrossRefGoogle Scholar
  79. Nigam A (2011) Senescence (ageing) @ 2011. Indian J Dermatol 56:615–621PubMedPubMedCentralCrossRefGoogle Scholar
  80. Ostan R, Lanzarini C, Pini E et al (2015) Inflammaging and cancer: a challenge for the mediterranean diet. Nutrients 7:2589–2621PubMedPubMedCentralCrossRefGoogle Scholar
  81. Palmeri M, Misiano G, Malaguarnera M et al (2012) Cytokine serum profile in a group of Sicilian nonagenarians. J Immunoassay Immunochem 33:82–90PubMedCrossRefGoogle Scholar
  82. Pawelec G, Barnett Y, Forsey R et al (2002) T cells and aging, January 2002 update. Front Biosci 7:d1056–d1183PubMedGoogle Scholar
  83. Pes GM, Lio D, Carru C et al (2004) Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin Exp Res 16:244–248PubMedCrossRefGoogle Scholar
  84. Pola R, Gaetani E, Flex A et al (2002) 174 G/C interleukin-6 gene polymorphism and increased risk of multi-infarct dementia: a case–control study. Exp Gerontol 37:949–955PubMedCrossRefGoogle Scholar
  85. Rea IM, Stewart M, Campbell P et al (1996) Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology 42:69–78PubMedCrossRefGoogle Scholar
  86. Rea IM, McNerlan S, Pockley AG (2001) Serum heat shock protein and anti-heat shock protein antibody levels in aging. Exp Gerontol 36:341–352PubMedCrossRefGoogle Scholar
  87. Rea IM, Ross OA, Armstrong M et al (2003) Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev 124:555–561PubMedCrossRefGoogle Scholar
  88. Rea IM, Maxwell LD, McNerlan SE et al (2013) Killer Immunoglobulin-like receptors (KIR) haplogroups A and B track with natural killer cells and cytokine profile in aged subjects: observations from octo/nonagenarians in the belfast elderly longitudinal free-living aging study (BELFAST). Immun Ageing 10:35PubMedPubMedCentralCrossRefGoogle Scholar
  89. Rink L, Cakman I, Kirchner H (1998) Altered cytokine production in the elderly. Mech Ageing Dev 102:199–209PubMedCrossRefGoogle Scholar
  90. Ross OA, Curran MD, Meenagh A et al (2003a) Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 124:199–206PubMedCrossRefGoogle Scholar
  91. Ross OA, Curran MD, Rea IM et al (2003b) HLA haplotypes and TNF polymorphism do not associate with longevity in the Irish. Mech Ageing Dev 124:563–567PubMedCrossRefGoogle Scholar
  92. Roubenoff R, Parise H, Payette HA et al (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 115:429–435PubMedCrossRefGoogle Scholar
  93. Safranow K, Dziedziejko V, Rzeuski R et al (2009) Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Tissue Antigens 74:386–392PubMedCrossRefGoogle Scholar
  94. Salvioli S, Capri M, Valensin S et al (2006) Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr Pharm Des 12:3161–3171PubMedCrossRefGoogle Scholar
  95. Salvioli S, Capri M, Bucci L et al (2009) Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother 58:1909–1917PubMedCrossRefGoogle Scholar
  96. Salvioli S, Monti D, Lanzarini C et al (2013) Immune system, cell senescence, aging and longevity–inflamm-aging reappraised. Curr Pharm Des 19:1675–1679PubMedGoogle Scholar
  97. Sanchez I, Santana S, Escobar C et al (2014) Clinical implications of different biomarkers in elderly patients with heart failure. Biomark Med 8:535–541PubMedCrossRefGoogle Scholar
  98. Sanjabi S, Zenewicz LA, Kamanaka M et al (2009) Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9:447–453PubMedPubMedCentralCrossRefGoogle Scholar
  99. Sansoni P, Vescovini R, Fagnoni F et al (2008) The immune system in extreme longevity. Exp Gerontol 43:61–65PubMedCrossRefGoogle Scholar
  100. Saxena A, Khosraviani S, Noel S et al (2015) Interleukin-10 paradox: a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine 74:27–34PubMedCrossRefGoogle Scholar
  101. Scola L, Candore G, Colonna-Romano G et al (2005) Study of the association with -330T/G IL-2 in a population of centenarians from centre and south Italy. Biogerontology 6:425–429PubMedCrossRefGoogle Scholar
  102. Takano T, Fiore S, Maddox JF et al (1997) Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185:1693–1704PubMedPubMedCentralCrossRefGoogle Scholar
  103. Temajo NO, Howard N (2014) The virus-induced HSPs regulate the apoptosis of operates APCs that results in autoimmunity, not in homeostasis. Autoimmun Rev 13:1013–1019PubMedCrossRefGoogle Scholar
  104. Terry DF, Wyszynski DF, Nolan VG et al (2006) Serum heat shock protein 70 level as a biomarker of exceptional longevity. Mech Ageing Dev 127:862–868PubMedPubMedCentralCrossRefGoogle Scholar
  105. Tonet AC, Karnikowski M, Moraes CF et al (2008) Association between the −174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res 41:47–53PubMedCrossRefGoogle Scholar
  106. Udono H (2012) Heat shock protein magic in antigen trafficking within dendritic cells: implications in antigen cross-presentation in immunity. Acta Med Okayama 66:1–6PubMedGoogle Scholar
  107. Van Den Biggelaar AH, De Craen AJ, Gussekloo J et al (2004) Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming. FASEB J 18:1022–1024Google Scholar
  108. van den Biggelaar AH, Gussekloo J, de Craen AJ et al (2007) Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 42:693–701PubMedCrossRefGoogle Scholar
  109. Varadhan R, Yao W, Matteini A et al (2014) Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J Gerontol A Biol Sci Med Sci 69:165–173PubMedCrossRefGoogle Scholar
  110. Vina J, Gambini J, Lopez-Grueso R et al (2011) Females live longer than males: role of oxidative stress. Curr Pharm Des 17:3959–3965PubMedCrossRefGoogle Scholar
  111. Wang XY, Hurme M, Jylhä M et al (2001) Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev 123:29–38PubMedCrossRefGoogle Scholar
  112. Wolf J, Rose-John S, Garbers C (2014) Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 70:11–20PubMedCrossRefGoogle Scholar
  113. Wolk K, Witte E, Witte K et al (2010) Biology of interleukin-22. Semin Immunopathol 32:17–31PubMedCrossRefGoogle Scholar
  114. Yende S, Tuomanen EI, Wunderink R et al (2005) Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med 172:1440–1446PubMedPubMedCentralCrossRefGoogle Scholar
  115. Zanni F, Vescovini R, Biasini C et al (2003) Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 38:981–987PubMedCrossRefGoogle Scholar

Copyright information

© L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2015

Authors and Affiliations

  • Paola Lucia Minciullo
    • 1
  • Antonino Catalano
    • 2
  • Giuseppe Mandraffino
    • 3
  • Marco Casciaro
    • 1
  • Andrea Crucitti
    • 2
  • Giuseppe Maltese
    • 4
  • Nunziata Morabito
    • 2
  • Antonino Lasco
    • 2
  • Sebastiano Gangemi
    • 1
  • Giorgio Basile
    • 2
  1. 1.Unit and School of Allergy and Clinical Immunology, Department of Clinical and Experimental MedicineUniversity of MessinaMessinaItaly
  2. 2.Unit and School of Geriatrics, Department of Clinical and Experimental MedicineUniversity of MessinaMessinaItaly
  3. 3.Unit of Internal Medicine, Department of Clinical and Experimental MedicineUniversity of MessinaMessinaItaly
  4. 4.Unit For Metabolic Medicine, Cardiovascular DivisionKing’s College LondonLondonUK

Personalised recommendations